- FASTA Sequence
- PDBx/mmCIF Format
- PDBx/mmCIF Format (gz)
- BinaryCIF Format (gz)
- Legacy PDB Format
- Legacy PDB Format (gz)
- PDBML/XML Format (gz)
- Structure Factors (CIF)
- Structure Factors (CIF - gz)
- Validation Full (PDF - gz)
- Validation (XML - gz)
- Validation (CIF - gz)
- Validation 2fo-fc coefficients (CIF - gz)
- Validation fo-fc coefficients (CIF - gz)
- Biological Assembly 1 (CIF - gz)
- Biological Assembly 1 (PDB - gz)
5J94 | pdb_00005j94
Human cathepsin K mutant C25S in complex with the allosteric effector NSC13345
- PDB DOI: https://doi.org/10.2210/pdb5J94/pdb
- Entry: 5J94 supersedes: 4LEG
- Classification: HYDROLASE
- Organism(s): Homo sapiens
- Expression System: Escherichia coli BL21(DE3)
- Mutation(s): Yes
- Deposited: 2016-04-08 Released: 2016-04-20
- Deposition Author(s): Novinec, M., Korenc, M., Lenarcic, B., Baici, A.
- Funding Organization(s): Slovenian Research Agency
Experimental Data Snapshot
- Method: X-RAY DIFFRACTION
- Resolution: 2.22 Γ
- R-Value Free: 0.234 (Depositor), 0.229 (DCC)
- R-Value Work: 0.212 (Depositor), 0.214 (DCC)
- R-Value Observed: 0.213 (Depositor)
Starting Model: experimental
View more details
Literature
- π Image
Download Mendeley
A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods.
Novinec, M., Korenc, M., Caflisch, A., Ranganathan, R., Lenarcic, B., Baici, A.(2014) Nat Commun 5: 3287
- PubMed: 24518821 Search on PubMed
- DOI: https://doi.org/10.1038/ncomms4287
- Primary Citation Related Structures:
5J94 - PubMed Abstract:
Allosteric modifiers have the potential to fine-tune enzyme activity. Therefore, targeting allosteric sites is gaining increasing recognition as a strategy in drug design. Here we report the use of computational methods for the discovery of the first small-molecule allosteric inhibitor of the collagenolytic cysteine peptidase cathepsin K, a major target for the treatment of osteoporosis. The molecule NSC13345 is identified by high-throughput docking of compound libraries to surface sites on the peptidase that are connected to the active site by an evolutionarily conserved network of residues (protein sector). The crystal structure of the complex shows that NSC13345 binds to a novel allosteric site on cathepsin K. The compound acts as a hyperbolic mixed modifier in the presence of a synthetic substrate, it completely inhibits collagen degradation and has good selectivity for cathepsin K over related enzymes. Altogether, these properties qualify our methodology and NSC13345 as promising candidates for allosteric drug design.
- 1] Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland [2] Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Cesta v Mestni log 88A, SI-1000 Ljubljana, Slovenia.
- Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Cesta v Mestni log 88A, SI-1000 Ljubljana, Slovenia.
- Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
- Green Center for Systems Biology, UT Southwestern Medical Center, 6001 Forest Park Blvd., Dallas, Texas 75390-9050, USA.
- 1] Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Cesta v Mestni log 88A, SI-1000 Ljubljana, Slovenia [2] Department of Biochemistry and Molecular and Structural Biology, JoΕΎef Stefan Institute, Jamova cesta 39, SI-1000 Ljubljana, Slovenia.
Organizational Affiliation:
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (1XF)
Biological Assembly 1
Explore in 3D: Structure | Sequence Annotations | Electron Density | Validation Report | Ligand Interaction (1XF)
Global Symmetry: Asymmetric - C1
Global Stoichiometry: Monomer - A1
Find Similar Assemblies
Biological assembly 1 assigned by authors and generated by PISA (software)
Macromolecule Content
- Total Structure Weight: 24.89 kDa
- Atom Count: 1,877
- Modeled Residue Count: 223
- Deposited Residue Count: 223
- Unique protein chains: 1
Macromolecules
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Cathepsin K | 223 | Homo sapiens | Mutation(s): 1 Gene Names: CTSK, CTSO, CTSO2 EC: 3.4.22.38 | π Image | |
UniProt & NIH Common Fund Data Resources | |||||
PHAROS: P43235 GTEx: ENSG00000143387 | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P43235 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Small Molecules
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| 1XF Download:Ideal Coordinates CCD File | B [auth A] | 2-{[(carbamoylsulfanyl)acetyl]amino}benzoic acid C10 H10 N2 O4 S NWUAPELPCMQTDN-UHFFFAOYSA-N | π Image | ||
| SO4 Download:Ideal Coordinates CCD File | C [auth A] | SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L | π Image | ||
Experimental Data & Validation
Experimental Data
- Method: X-RAY DIFFRACTION
- Resolution: 2.22 Γ
- R-Value Free: 0.234 (Depositor), 0.229 (DCC)
- R-Value Work: 0.212 (Depositor), 0.214 (DCC)
- R-Value Observed: 0.213 (Depositor)
| Length ( Γ ) | Angle ( Λ ) |
|---|---|
| a = 49.345 | Ξ± = 90 |
| b = 56.101 | Ξ² = 90 |
| c = 74.556 | Ξ³ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| PDB_EXTRACT | data extraction |
| SAINT | data reduction |
| PHASER | phasing |
| SADABS | data scaling |
Entry History
& Funding InformationDeposition Data
- Released Date: 2016-04-20 Deposition Author(s): Novinec, M., Korenc, M., Lenarcic, B., Baici, A.
- This entry supersedes: 4LEG
| Funding Organization | Location | Grant Number |
|---|---|---|
| Slovenian Research Agency | Slovenia | Z1-4077 |
| Slovenian Research Agency | Slovenia | P1-0140 |
Revision History (Full details and data files)
- Version 1.0: 2016-04-20
Type: Initial release - Version 1.1: 2024-01-10
Changes: Data collection, Database references, Refinement description - Version 1.2: 2024-11-20
Changes: Structure summary
